We are live on ! Find out more
FLSM

Frazier Life Sciences Management Portfolio holdings

AUM $3.89B
1-Year Est. Return 201.1%
This Fund
S&P 500
This Quarter Est. Return
+34.04%
1 Year Est. Return
+201.1%
3 Year Est. Return
+879.31%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$3.89B
AUM Growth
+$163M
Cap. Flow
+$27.4M
Cap. Flow %
0.71%
Top 10 Hldgs %
73.49%
Holding
43
New
3
Increased
8
Reduced
10
Closed
5

Top Buys

1
MIRM icon
Mirum Pharmaceuticals
MIRM
+$83.2M
2
BCRX icon
BioCryst Pharmaceuticals
BCRX
+$31.1M
3
ERAS icon
Erasca
ERAS
+$23M
4
GLUE icon
Monte Rosa Therapeutics
GLUE
+$19.1M
5
PVLA
Palvella Therapeutics
PVLA
+$16.7M

Top Sells

1
RNAM
Avidity Biosciences
RNAM
+$70.9M
2
ABVX
Abivax
ABVX
+$51M
3
RAPT
RAPT Therapeutics
RAPT
+$33.3M
4
RVMD icon
Revolution Medicines
RVMD
+$12.3M
5
TVTX icon
Travere Therapeutics
TVTX
+$9.23M

Sector Composition

1 Healthcare 99.74%

No holdings matched the selected filter criteria.

1 2

Similar funds

GAMH
Greenwoods Asset Management (HK) Hong Kong $3.88B AUM 23.82% 1-Year Est. Return
MSI
Mitsui Sumitomo Insurance Tokyo, Japan $3.9B AUM
CCM
Channing Capital Management Chicago, Illinois $3.91B AUM 34.32% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
MIM
Meridiem Investment Management London, United Kingdom $3.92B AUM 1.64% 1-Year Est. Return
AA
Alesco Advisors Pittsford, New York $3.92B AUM 15.21% 1-Year Est. Return
DACG
Donor Advised Charitable Giving San Francisco, California $3.92B AUM 59.92% 1-Year Est. Return